Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis-Reference-Cited by-同舟云学术

Development of a prognostic risk score to aid antibiotic decision-making for children aged 2-59 months with World Health Organization fast breathing pneumonia in Malawi: An Innovative Treatments in Pneumonia (ITIP) secondary analysis

Published:2019-06-20 Issue:6 Volume:14 Page:e0214583
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

McCollum Eric D.^ORCID,Brown Siobhan P.,Nkwopara Evangelyn,Mvalo Tisungane,May Susanne,Ginsburg Amy Sarah

Funder

Bill and Melinda Gates Foundation

Fogarty International Center

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals;L Liu;Lancet,2017

2. Integrated Management of Childhood Illness: Chart Booklet,2014

3. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials;S Sazawal;Lancet Infect Dis,2003

4. Burden of Streptococcus pneumoniae and Haemophilus influenzae type b disease in children in the era of conjugate vaccines: global, regional, and national estimates for 2000–15;B Wahl;Lancet Glob Health,2018

5. A role for Streptococcus pneumoniae in virus-associated pneumonia;SA Madhi;Nat Med,2004

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assembling a global database of child pneumonia studies to inform WHO pneumonia management algorithm: Methodology and applications;Journal of Global Health;2022-12-29

2. External validation of the RISC, RISC-Malawi, and PERCH clinical prediction rules to identify risk of death in children hospitalized with pneumonia;Journal of Global Health;2021-10-09

3. Antibiotic therapy versus no antibiotic therapy for children aged 2 to 59 months with WHO-defined non-severe pneumonia and wheeze;Cochrane Database of Systematic Reviews;2021-01-20

4. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze;Cochrane Database of Systematic Reviews;2012-01-18